Multi-dose use 28-day in-use period Safe for repeated needle penetration
In practical terms, that means: Before starting treatment: You will need to show that you are actively participating in an intensive behavioral therapy (IBT) program While on the medication: You will need to continue that participation For approval: Carriers will use prior authorization to verify both This formalizes something that was already happening in some plans, but raises the bar and makes it a more consistent expectation across FEHB carriers
10.1016/j.jid.2023.01.045 [DOI] [PMC free article] [PubMed] [Google Scholar] 67.Williams NM et al
2016, Apr, 8;352(6282):23135 Milanovi M, Beki M, oki J, Vuevi D, oli M, Tomi S
To everyone in Lisbon this week: have an excellent meeting
GLP-1 medications can improve metabolic markers like insulin sensitivity and aid weight loss, which effectively "speeds up" your metabolic outcomes